Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07248046 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study)

Study acronym: SMOM
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 27, 2026 (before its estimated September 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Enrollment closed, study ongoing
    • Study completion pushed from Nov 15, 2026 to Dec 15, 2026
    • Site details revised
    v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Jul 15, 2026 to Sep 15, 2026
    • Study completion date: Sep 15, 2026 to Nov 15, 2026
    • Site details revised
    v3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will compare different combinations of fertility signs (cervical mucus (CM), luteinizing hormone \[LH\], pregnanediol glucuronide \[PDG\], and basal body temperature \[BBT\]) to determine which are most reliable for identifying ovulation and luteal phase length. Thirty existing Premom App users will track daily observations for three menstrual cycles. Participants will record mucus, perform urine tests, upload test strip photos to the Premom App, and measure BBT. Both participant readings and AI-assisted app readings will be analyzed. The main goal is to find which marker pairings give the most accurate picture of ovulation timing and luteal phase length. Secondary goals include understanding ease of use, the number of tests required, and whether the app improves accuracy.
Trial Details
NCT Number NCT07248046
Lead Sponsor Bruyère Health Research Institute.
Conditions
(from sponsor)		 Fertility, Mobile Applications, Artifical Intelligence, Cervical Mucus, Body Temperature, Luteinizing Hormone (LH), Ovulation, Menstrual Cycle +1 more
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov